Household-level effects of seasonal malaria chemoprevention in the Gambia. [PDF]
In 2022 the WHO recommended the discretionary expansion of the eligible age range for seasonal malaria chemoprevention (SMC) to children older than 4 years.
Soremekun S +11 more
europepmc +8 more sources
Seasonal malaria chemoprevention in northern Mozambique: a cost-effectiveness analysis. [PDF]
Malaria is endemic in Mozambique and one of the leading causes of death in children under 5 years old. In 2020 the country adopted the WHO-recommended seasonal malaria chemoprevention (SMC) strategy and delivered the intervention in all 23 districts of ...
Canana N +9 more
europepmc +5 more sources
Combining seasonal malaria chemoprevention with novel therapeutics for malaria prevention: a mathematical modelling study. [PDF]
Background: Vaccines, monoclonal antibodies, and long-acting injectables are being developed to prevent Plasmodium falciparum malaria. These therapeutics may target multiple stages of the parasite life cycle, and evidence is needed to articulate their ...
Braunack-Mayer L +5 more
europepmc +5 more sources
Parasitological efficacy of seasonal malaria chemoprevention in Nampula, northern Mozambique. [PDF]
Background Deployment of seasonal malaria chemoprevention (SMC) for young children using monthly sulphadoxine-pyrimethamine-amodiaquine (SPAQ) has recently been extended to Central and East Africa.
Bonnington C +12 more
europepmc +4 more sources
Evaluation of seasonal malaria chemoprevention implementation in the Upper East region of Northern Ghana. [PDF]
Ghana adopted the WHO-recommended Seasonal Malaria Chemoprevention (SMC) in 2016 following a pilot study as a vital strategy for malaria control.
Ayamba EY +8 more
europepmc +5 more sources
Estimating the potential public health impact of seasonal malaria chemoprevention in African children [PDF]
Seasonal malaria chemoprevention, previously known as intermittent preventive treatment in children, is highly effective in areas with a short malaria transmission season.
Matthew Cairns +2 more
exaly +15 more sources
Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire [PDF]
Seasonal malaria chemoprevention (SMC) is a strategy recommended by the World Health Organization for children aged 3–59 months in the Sahel and sub-Sahel regions where malaria transmission is seasonal. In Côte d’Ivoire, malaria remains a high priority and accounts for the majority of consultations and deaths in children under five. The recent revision
Issaka Zongo +2 more
exaly +5 more sources
Impact of seasonal malaria chemoprevention timing on clinical malaria incidence dynamics in the Kedougou region, Senegal. [PDF]
Seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine is recommended by the World Health Organization since 2012 for clinical malaria prevention in children in the Sahelian region of Africa.
Kazanga B +12 more
europepmc +6 more sources
Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention [PDF]
Malaria control remains a challenge in many parts of the Sahel and sub-Sahel regions of Africa.We conducted an individually randomized, controlled trial to assess whether seasonal vaccination with RTS,S/AS01E was noninferior to chemoprevention in preventing uncomplicated malaria and whether the two interventions combined were superior to either one ...
Issaka Zongo +2 more
exaly +3 more sources
Pharmacokinetic considerations in seasonal malaria chemoprevention
Los niños africanos menores de 5 años soportan la principal carga de la mortalidad mundial por malaria. La quimioprevención estacional de la malaria (SMC) con sulfadoxina-pirimetamina (SP) más amodiaquina (AQ) administrada mensualmente durante la temporada de lluvias es una intervención altamente efectiva contra la malaria para niños de entre 3 meses y
Palang Chotsiri +2 more
exaly +3 more sources

